| Israele | Turchia | Austria | |
| Rimozione della vescica | da $28,500 | da $8,000 | da $22,000 |
| Immunoterapia con Keytruda (Pembrolizumab) | da $9,800 | da $3,300 | da $15,000 |
| Chemioterapia Intraperitoneale Ipertermica (HIPEC) | da $42,000 | da $22,500 | da $40,000 |
| Terapia con Bacillo di Calmette-Guérin (BCG) | - | da $1,200 | da $2,400 |
| Terapia con Actinio-225 | - | da $22,955 | da $55,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Tumore della vescica. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Tumore della vescica e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Tumore della vescica.
Dr. Tamar Jablonski-Perec is an oncologist at Hadassah Medical Center in Jerusalem. She holds a Doctor of Medical Sciences from the Hebrew University and has experience from the renowned Sloan-Kettering Cancer Center in New York. She is the Head of Institute of Oncology, Head of Breast Cancer Treatment Center, and Professor of the Department of Oncology at the Hebrew University. She is a member of several international cancer communities and was awarded a scholarship from the Hadassah Medical School.
Dr. Vladimir Yutkin, MD, is the Director of Urologic Oncology, Robotic, and Advanced Laparoscopic Surgery at Hadassah Medical Center. He has over 20 years of experience treating urological cancers. Dr. Yutkin also co-directs the Endo-Urology Society Fellowship. He is known for his expertise in minimally invasive surgical techniques.
Dr. Yutkin graduated from the Hebrew University of Jerusalem in 1996. He has performed many successful procedures, helping to improve patient survival and recovery. Dr. Yutkin speaks English, Hebrew, and Russian. He is a respected leader in urologic oncology.